MENU
+Compare
XLV
ETF ticker: NYSE ARCA
AS OF
Feb 3, 04:59 PM (EDT)
Price
$154.07
Change
+$9.88 (+6.85%)
Net Assets
40.98B

XLV stock forecast, quote, news & analysis

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index... Show more

Category: #Health
XLV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I.Advisor
a Summary for XLV with price predictions
Feb 02, 2026

XLV's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for XLV moved out of overbought territory on January 08, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLV as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XLV turned negative on January 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

XLV moved above its 50-day moving average on February 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .

XLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 302 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Intuitive Surgical (NASDAQ:ISRG), Pfizer (NYSE:PFE).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the State Street®HlthCrSelSectSPDR®ETF ETF is 93.82B. The market cap for tickers in the group ranges from 7.85B to 934.52B. LLY holds the highest valuation in this group at 934.52B. The lowest valued company is DVA at 7.85B.

High and low price notable news

The average weekly price growth across all stocks in the State Street®HlthCrSelSectSPDR®ETF ETF was 28%. For the same ETF, the average monthly price growth was 37%, and the average quarterly price growth was 68%. MRK experienced the highest price growth at 6%, while HUM experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the State Street®HlthCrSelSectSPDR®ETF ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was 48% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 57
Price Growth Rating: 42
SMR Rating: 56
Profit Risk Rating: 71
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
XLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com